4.6 Article

Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization

Journal

CELL CYCLE
Volume 9, Issue 5, Pages 971-974

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cc.9.5.10914

Keywords

Skp2, S-phase-associated kinase 2; APC/C, anaphase promoting complex/cyclosome; CDK, cyclin-dependent kinase; PKB, protein kinase B

Categories

Funding

  1. NHMRC
  2. AICF
  3. FIRC
  4. National Institutes of Health [R01-GM57587, R37-CA76584, R21-CA125173]
  5. Multiple Myeloma Research Foundation
  6. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

Ask authors/readers for more resources

F-box proteins are the substrate recognition subunits of SCF (Skp1, Cul1, F-box protein) ubiquitin ligase complexes. Skp2 is a nuclear F-box protein that targets the CDK inhibitor p27 for ubiquitin-and proteasome-dependent degradation. In G(0) and during the G(1) phase of the cell cycle, Skp2 is degraded via the APC/C(Cdh1) ubiquitin ligase to allow stabilization of p27 and inhibition of CDKs, facilitating the maintenance of the G(0)/G(1) state. APC/C(Cdh1) binds Skp2 through an N-terminal domain (amino acids 46-94 in human Skp2). It has been shown that phosphorylation of Ser64 and Ser72 in this domain dissociates Skp2 from APC/C. More recently, it has instead been proposed that phosphorylation of Skp2 on Ser72 by Akt/PKB allows Skp2 binding to Skp1, promoting the assembly of an active SCF(Skp2) ubiquitin ligase, and Skp2 relocalization/retention into the cytoplasm, promoting cell migration via an unknown mechanism. According to these reports, a Skp2 mutant in which Ser72 is substituted with Ala is unable to promote cell proliferation and loses its oncogenic potential. Given the contrasting reports, we revisited these results and conclude that phosphorylation of Skp2 on Ser72 does not control Skp2 binding to Skp1 and Cul1, has no influence on SCFSkp2 ubiquitin ligase activity, and does not affect the subcellular localization of Skp2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

FBXL5 Regulates IRP2 Stability in Iron Homeostasis via an Oxygen-Responsive [2Fe2S] Cluster

Hui Wang, Hui Shi, Malini Rajan, Elizabeth R. Canarie, Seoyeon Hong, Daniele Simoneschi, Michele Pagano, Matthew F. Bush, Stefan Stoll, Elizabeth A. Leibold, Ning Zheng

MOLECULAR CELL (2020)

Article Multidisciplinary Sciences

PHOTACs enable optical control of protein degradation

Martin Reynders, Bryan S. Matsuura, Marleen Berouti, Daniele Simoneschi, Antonio Marzio, Michele Pagano, Dirk Trauner

SCIENCE ADVANCES (2020)

Editorial Material Biochemistry & Molecular Biology

Loss of the deubiquitinase OTULIN promotes hepatocellular carcinoma (HCC) in an mTOR-dependent manner

Antonio Marzio, Michele Pagano

CELL DEATH AND DIFFERENTIATION (2020)

Article Cell Biology

Interaction between NSMCE4A and GPS1 links the SMC5/6 complex to the COP9 signalosome

Andras Horvath, Gergely Rona, Michele Pagano, Philip W. Jordan

BMC MOLECULAR AND CELL BIOLOGY (2020)

Article Cell Biology

APC/CCdh1 is required for the termination of chromosomal passenger complex activity upon mitotic exit

Takaaki Tsunematsu, Rieko Arakaki, Hidehiko Kawai, Jan Ruppert, Koichi Tsuneyama, Naozumi Ishimaru, William C. Earnshaw, Michele Pagano, Yasusei Kudo

JOURNAL OF CELL SCIENCE (2020)

Article Cell Biology

Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis

Loredana Moro, Daniele Simoneschi, Emma Kurz, Arnaldo A. Arbini, Shaowen Jang, Nicoletta Guaragnella, Sergio Giannattasio, Wei Wang, Yu-An Chen, Geoffrey Pires, Andrew Dang, Elizabeth Hernandez, Payal Kapur, Ankita Mishra, Aristotelis Tsirigos, George Miller, Jer-Tsong Hsieh, Michele Pagano

NATURE CELL BIOLOGY (2020)

Article Biology

Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments

Hajnalka L. Palinkas, Angela Bekesi, Gergely Rona, Lorinc Pongor, Gabor Papp, Gergely Tihanyi, Eszter Holub, Adam Poti, Carolina Gemma, Simak Ali, Michael J. Morten, Eli Rothenberg, Michele Pagano, David Szuts, Balazs Gyorffy, Beata G. Vertessy

ELIFE (2020)

Editorial Material Cell Biology

Linking ubiquitin to actin dynamics during cell fusion

Luca Lignitto, Michele Pagano

Summary: Cell-cell fusion, crucial for the development of multicellular organisms, is driven by the remodeling of the actin cytoskeleton. A recent study reveals how CRL3-dependent mono-ubiquitylation regulates cell fusion by controlling the dynamics of cytoskeletal rearrangements.

DEVELOPMENTAL CELL (2021)

Article Biochemistry & Molecular Biology

Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation

Marco Salamina, Bailey C. Montefiore, Mengxi Liu, Daniel J. Wood, Richard Heath, James R. Ault, Lan-Zhen Wang, Svitlana Korolchuk, Arnaud Basle, Martyna W. Pastok, Judith Reeks, Natalie J. Tatum, Frank Sobott, Stefan T. Arold, Michele Pagano, Martin E. M. Noble, Jane A. Endicott

Summary: The SCFSKP2 ubiquitin ligase promotes degradation of p27KIP1 to relieve G1 checkpoint control of CDK-cyclin complexes, ensuring orderly cell cycle progression. The interaction between SKP2 and cyclin A provides a structural mechanism for fine-tuning the degradation of p27KIP1 and distinguishes cyclin A from other G1 cyclins.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Multidisciplinary Sciences

AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

Emiliano Maiani, Giacomo Milletti, Francesca Nazio, Sos Gronbaek Holdgaard, Jirina Bartkova, Salvatore Rizza, Valentina Cianfanelli, Mar Lorente, Daniele Simoneschi, Miriam Di Marco, Pasquale D'Acunzo, Luca Di Leo, Rikke Rasmussen, Costanza Montagna, Marilena Raciti, Cristiano De Stefanis, Estibaliz Gabicagogeascoa, Gergely Rona, Nelida Salvador, Emanuela Pupo, Joanna Maria Merchut-Maya, Colin J. Daniel, Marianna Carinci, Valeriana Cesarini, Alfie O'sullivan, Yeon-Tae Jeong, Matteo Bordi, Francesco Russo, Silvia Campello, Angela Gallo, Giuseppe Filomeni, Letizia Lanzetti, Rosalie C. Sears, Petra Hamerlik, Armando Bartolazzi, Robert E. Hynds, David R. Pearce, Charles Swanton, Michele Pagano, Guillermo Velasco, Elena Papaleo, Daniela De Zio, Apolinar Maya-Mendoza, Franco Locatelli, Jiri Bartek, Francesco Cecconi

Summary: AMBRA1 has been identified as a key regulator in cell cycle control, playing a crucial role in maintaining genomic integrity by regulating the abundance of D-type cyclins and facilitating the transition from G1 to S phase, thereby preventing replication stress. The findings suggest that CHK1 kinase could be a potential therapeutic target in AMBRA1-deficient tumors, highlighting the importance of the AMBRA1-cyclin D pathway in regulating cell cycle and genomic stability in embryonic development and tumorigenesis.

NATURE (2021)

Article Multidisciplinary Sciences

CRL4AMBRA1 is a master regulator of D-type cyclins

Daniele Simoneschi, Gergely Rona, Nan Zhou, Yeon-Tae Jeong, Shaowen Jiang, Giacomo Milletti, Arnaldo A. Arbini, Alfie O'Sullivan, Andrew A. Wang, Sorasicha Nithikasem, Sarah Keegan, Yik Siu, Valentina Cianfanelli, Emiliano Maiani, Francesca Nazio, Francesco Cecconi, Francesco Boccalatte, David Fenyo, Drew R. Jones, Luca Busino, Michele Pagano

Summary: The research identifies AMBRA1 as a ubiquitin ligase that degrades D-type cyclins, whose loss leads to accumulation of D-type cyclins and tumorigenesis. Furthermore, AMBRA1 also affects the sensitivity to CDK4/6 inhibitors.

NATURE (2021)

Article Multidisciplinary Sciences

ORF10?Cullin-2?ZYG11B complex is not required for SARS-CoV-2 infection

Elijah L. Mena, Callie J. Donahue, Laura Pontano Vaites, Jie Li, Gergely Rona, Colin O'Leary, Luca Lignitto, Bearach Miwatani-Minter, Joao A. Paulo, Avantika Dhabaria, Beatrix Ueberheide, Steven P. Gygi, Michele Pagano, J. Wade Harper, Robert A. Davey, Stephen J. Elledge

Summary: The study found an interaction between ORF10 and CRL2ZYG11B but no evidence that ORF10 is functioning to inhibit or hijack CRL2ZYG11B.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors

Giang Thanh Nguyen-Dien, Keri-Lyn Kozul, Yi Cui, Brendan Townsend, Prajakta Gosavi Kulkarni, Soo Siang Ooi, Antonio Marzio, Nissa Carrodus, Steven Zuryn, Michele Pagano, Robert G. Parton, Michael Lazarou, S. Sean Millard, Robert W. Taylor, Brett M. Collins, Mathew J. K. Jones, Julia K. Pagan

Summary: To maintain mitochondrial quality and quantity, cells use mitophagy to selectively remove damaged or excessive mitochondria. SCFFBXL4, a protein ubiquitin ligase complex that localises to the mitochondrial outer membrane, plays a role in constitutive ubiquitylation and degradation of mitophagy receptors NIX and BNIP3, thus suppressing basal levels of mitophagy.

EMBO JOURNAL (2023)

Article Oncology

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer

Jiehui Deng, Aatish Thennavan, Igor Dolgalev, Ting Chen, Jie Li, Antonio Marzio, John T. Poirier, David H. Peng, Mirna Bulatovic, Subhadip Mukhopadhyay, Heather Silver, Eleni Papadopoulos, Val Pyon, Cassandra Thakurdin, Han Han, Fei Li, Shuai Li, Hailin Ding, Hai Hu, Yuanwang Pan, Vajira Weerasekara, Baishan Jiang, Eric S. Wang, Ian Ahearn, Mark Philips, Thales Papagiannakopoulos, Aristotelis Tsirigos, Eli Rothenberg, Justin Gainor, Gordon J. Freeman, Charles M. Rudin, Nathanael S. Gray, Peter S. Hammerman, Michele Pagano, John V. Heymach, Charles M. Perou, Nabeel Bardeesy, Kwok-Kin Wong

Summary: The study found that LKB1-deficient lung tumors are sensitive to autophagy inhibition, which can restore impaired antigen presentation and antitumor immune responses, enhancing the effectiveness of PD-1 immunotherapy. Additionally, LKB1 deficiency inhibits antigen processing and presentation, but this can be reversed by targeting the autophagy pathway to restore immunoproteasome activity and antigen presentation.

NATURE CANCER (2021)

Article Oncology

Epigenetic suppression of FBXL7 promotes metastasis

Loredana Moro, Michele Pagano

MOLECULAR & CELLULAR ONCOLOGY (2020)

No Data Available